Cargando…

Response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring TPM3-ROS1 fusion

Detalles Bibliográficos
Autores principales: Cai, Cun-Liang, Zhang, Ming-Qiang, Guo, Jun, Wang, Li-Wan, Zhao, Jing-Quan, Guo, Wen-Jia, Mu, Xiang-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964956/
https://www.ncbi.nlm.nih.gov/pubmed/31833905
http://dx.doi.org/10.1097/CM9.0000000000000556
_version_ 1783488558668972032
author Cai, Cun-Liang
Zhang, Ming-Qiang
Guo, Jun
Wang, Li-Wan
Zhao, Jing-Quan
Guo, Wen-Jia
Mu, Xiang-Dong
author_facet Cai, Cun-Liang
Zhang, Ming-Qiang
Guo, Jun
Wang, Li-Wan
Zhao, Jing-Quan
Guo, Wen-Jia
Mu, Xiang-Dong
author_sort Cai, Cun-Liang
collection PubMed
description
format Online
Article
Text
id pubmed-6964956
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-69649562020-02-10 Response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring TPM3-ROS1 fusion Cai, Cun-Liang Zhang, Ming-Qiang Guo, Jun Wang, Li-Wan Zhao, Jing-Quan Guo, Wen-Jia Mu, Xiang-Dong Chin Med J (Engl) Correspondence Wolters Kluwer Health 2019-12-20 2019-12-20 /pmc/articles/PMC6964956/ /pubmed/31833905 http://dx.doi.org/10.1097/CM9.0000000000000556 Text en Copyright © 2019 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Correspondence
Cai, Cun-Liang
Zhang, Ming-Qiang
Guo, Jun
Wang, Li-Wan
Zhao, Jing-Quan
Guo, Wen-Jia
Mu, Xiang-Dong
Response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring TPM3-ROS1 fusion
title Response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring TPM3-ROS1 fusion
title_full Response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring TPM3-ROS1 fusion
title_fullStr Response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring TPM3-ROS1 fusion
title_full_unstemmed Response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring TPM3-ROS1 fusion
title_short Response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring TPM3-ROS1 fusion
title_sort response to crizotinib in a patient with metastatic lung spindle cell carcinoma harboring tpm3-ros1 fusion
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964956/
https://www.ncbi.nlm.nih.gov/pubmed/31833905
http://dx.doi.org/10.1097/CM9.0000000000000556
work_keys_str_mv AT caicunliang responsetocrizotinibinapatientwithmetastaticlungspindlecellcarcinomaharboringtpm3ros1fusion
AT zhangmingqiang responsetocrizotinibinapatientwithmetastaticlungspindlecellcarcinomaharboringtpm3ros1fusion
AT guojun responsetocrizotinibinapatientwithmetastaticlungspindlecellcarcinomaharboringtpm3ros1fusion
AT wangliwan responsetocrizotinibinapatientwithmetastaticlungspindlecellcarcinomaharboringtpm3ros1fusion
AT zhaojingquan responsetocrizotinibinapatientwithmetastaticlungspindlecellcarcinomaharboringtpm3ros1fusion
AT guowenjia responsetocrizotinibinapatientwithmetastaticlungspindlecellcarcinomaharboringtpm3ros1fusion
AT muxiangdong responsetocrizotinibinapatientwithmetastaticlungspindlecellcarcinomaharboringtpm3ros1fusion